The inhibition properties of the obtained compounds were evaluated against four selected CA isoforms, including cytosolic ones (hCA I and II), as well as the tumour-associated membrane-bound isoforms (hCA IX and XII). The gene discussed is CYP24A1; the disease is neoplasm.